Novonesis stock after-hours at EUR 55.69: plus 1.09 percent versus the Lang & Schwarz prior close
Published on 10/02/2026 at 21:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novonesis stock was at EUR 55.69 after-hours at 9:49 p.m. CEST on October 2, 2026, according to Lang & Schwarz. The price was up 1.09 percent versus the Lang & Schwarz prior close of EUR 55.09 on October 1, 2026.
Friday's after-hours indication
The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Novonesis stock.
MicroBioGen acquisition completed
Novonesis said on October 1, 2026, that it had completed its acquisition of MicroBioGen, an Australian biotechnology company focused on yeast strains for industrial applications and bioethanol. All regulatory approvals had been obtained and the transaction had closed, according to the Novonesis release.
The transaction builds on Novonesis' investment in MicroBioGen in 2013 and its existing 23 percent ownership stake. Novonesis said the acquisition adds yeast-breeding expertise and could support biosolutions across industries; the announcement was also distributed by GlobeNewswire.
